Shareholders should be given the chance to have a say on the future of the Woodford Patient Capital trust (WPCT) through a continuation vote, as the board was slammed for failing to act more independently of the manager, according to James Carthew, head of investment company research at QuotedData.
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
